EP0972050 - CSK HOMOLOGONS KINAZE (CHK) FOR DETECTING AND TREATING BREAST CANCER [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 28.12.2001 Database last updated on 26.07.2024 | Most recent event Tooltip | 28.12.2001 | Application deemed to be withdrawn | published on 13.02.2002 [2002/07] | Applicant(s) | For all designated states Beth Israel Deaconess Medical Center One Deaconess Drive Boston, MA 02215 / US | [2000/03] | Inventor(s) | 01 /
AVRAHAM, Hava 22 Heath Hill Road Brookline, MA 02135 / US | 02 /
GROOPMAN, Jerome, E. 79 Druce Street Brookline, MA 02146 / US | [2000/03] | Representative(s) | Harvey, David Gareth, et al Graham Watt & Co LLP St Botolph's House 7-9 St Botolph's Road Sevenoaks Kent TN13 3AJ / GB | [N/P] |
Former [2000/03] | Harvey, David Gareth, et al Graham Watt & Co. Riverhead Sevenoaks Kent TN13 2BN / GB | Application number, filing date | 98901751.2 | 07.01.1998 | [2000/03] | WO1998US00420 | Priority number, date | US19970035228P | 08.01.1997 Original published format: US 35228 P | US19970876882 | 16.06.1997 Original published format: US 876882 | [2000/03] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO9830704 | Date: | 16.07.1998 | Language: | EN | [1998/28] | Type: | A1 Application with search report | No.: | EP0972050 | Date: | 19.01.2000 | Language: | EN | The application published by WIPO in one of the EPO official languages on 16.07.1998 takes the place of the publication of the European patent application. | [2000/03] | Search report(s) | International search report - published on: | EP | 16.07.1998 | Classification | IPC: | C12N15/54, G01N33/50, C12N9/12, A61K38/45, A61K48/00, A61K9/127 | [2000/03] | CPC: |
C12N9/1205 (EP,US);
A61K38/45 (EP,US);
C07K14/71 (EP,US);
G01N33/573 (EP,US);
G01N33/57415 (EP,US);
A61K48/00 (EP,US);
| Designated contracting states | AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2000/03] | Title | German: | KINASEHOMOLOG CSK (CHK) ZUR ERKENNUNG UND BEHANDLUNG VON BRUSTKREBS | [2000/03] | English: | CSK HOMOLOGONS KINAZE (CHK) FOR DETECTING AND TREATING BREAST CANCER | [2000/03] | French: | KINASE HOMOLOGUE CSK (CHK) UTILISEE DANS LA DETECTION ET LE TRAITEMENT DU CANCER DU SEIN | [2000/03] | Entry into regional phase | 21.07.1999 | National basic fee paid | 21.07.1999 | Designation fee(s) paid | 21.07.1999 | Examination fee paid | Examination procedure | 09.07.1998 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 21.07.1999 | Examination requested [2000/03] | 01.08.2001 | Application deemed to be withdrawn, date of legal effect [2002/07] | 06.09.2001 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2002/07] | Fees paid | Renewal fee | 17.01.2000 | Renewal fee patent year 03 | Penalty fee | Additional fee for renewal fee | 31.01.2001 | 04   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [PX] - ZRIHAN-LICHT S ET AL, "Association of csk-homologous kinase (CHK) (formerly MATK) with HER-2/ErbB-2 in breast cancer cells.", J BIOL CHEM, JAN 17 1997, 272 (3) P1856-63, UNITED STATES, XP002066240 [PX] 1-11 * abstract * DOI: http://dx.doi.org/10.1074/jbc.272.3.1856 | [T] - ZRIHAN-LICHT S ET AL, "Csk homologous kinase, a novel signaling molecule, directly associates with the activated ErbB-2 receptor in breast cancer cells and inhibits their proliferation.", J BIOL CHEM, FEB 13 1998, 273 (7) P4065-72, UNITED STATES, XP002066241 DOI: http://dx.doi.org/10.1074/jbc.273.7.4065 | International search | [PX] - ZRIHAN-LICHT S ET AL, "Association of csk-homologous kinase (CHK) (formerly MATK) with HER-2/ErbB-2 in breast cancer cells.", J BIOL CHEM, JAN 17 1997, 272 (3) P1856-63, UNITED STATES, XP002066240 [PX] 1-11 * abstract * DOI: http://dx.doi.org/10.1074/jbc.272.3.1856 | [T] - ZRIHAN-LICHT S ET AL, "Csk homologous kinase, a novel signaling molecule, directly associates with the activated ErbB-2 receptor in breast cancer cells and inhibits their proliferation.", J BIOL CHEM, FEB 13 1998, 273 (7) P4065-72, UNITED STATES, XP002066241 DOI: http://dx.doi.org/10.1074/jbc.273.7.4065 |